Abstract:Neurologic disease is seen commonly in cats, with infectious causes accounting for 30-45% of cases. However, since a specific infection cannot be identified in 12-40% of these cases, it is essential that we try to understand these cases better in the hope that we can eventually identify the cause(s), and so determine how best to treat and/or prevent them.
“…In our study, MR imaging (MRI) did not appear to detect all cases of CNS inflammation in the population of cats with inflammatory cerebrospinal fluid (CSF); however, MRI adds information about the sites and morphology of intracranial lesions that should help to distinguish between neoplasia and inflammatory conditions and, possibly, between different inflammatory conditions. M eningoencephalitis in cats is most frequently associated with infections, including feline infectious peritonitis (FIP) and toxoplasmosis (Foley et al 1998, Gunn-Moore 2005. In a recent histological review of tissues from 286 cats with neurological disorders, 92 (32%) had inflammatory and/or infectious lesions affecting the central nervous system (CNS) (Bradshaw et al 2004).…”
Medical records and magnetic resonance (MR) images of 14 cats with inflammatory diseases affecting the central nervous system (CNS) were reviewed retrospectively. Cases included eight cats with feline infectious peritonitis and two cats with toxoplasmosis. Abnormalities affecting the CNS were observed in MR images in 10 (71%) cats. Intracranial lesions appeared as slightly hypointense foci in T1-weighted images in two (14%) cats, as hyperintense foci in T2-weighted images in seven (50%) cats and as hyperintense foci after intravenous administration of a gadolinium-based contrast medium in 10 (71%) cats. In six cats with lesions in T1- and/or T2-weighted images, additional lesions were visible in T1-weighted images obtained after gadolinium-based contrast medium administration. In three cats, lesions were visible only after contrast medium administration. In our study, MR imaging (MRI) did not appear to detect all cases of CNS inflammation in the population of cats with inflammatory cerebrospinal fluid (CSF); however, MRI adds information about the sites and morphology of intracranial lesions that should help to distinguish between neoplasia and inflammatory conditions and, possibly, between different inflammatory conditions.
“…In our study, MR imaging (MRI) did not appear to detect all cases of CNS inflammation in the population of cats with inflammatory cerebrospinal fluid (CSF); however, MRI adds information about the sites and morphology of intracranial lesions that should help to distinguish between neoplasia and inflammatory conditions and, possibly, between different inflammatory conditions. M eningoencephalitis in cats is most frequently associated with infections, including feline infectious peritonitis (FIP) and toxoplasmosis (Foley et al 1998, Gunn-Moore 2005. In a recent histological review of tissues from 286 cats with neurological disorders, 92 (32%) had inflammatory and/or infectious lesions affecting the central nervous system (CNS) (Bradshaw et al 2004).…”
Medical records and magnetic resonance (MR) images of 14 cats with inflammatory diseases affecting the central nervous system (CNS) were reviewed retrospectively. Cases included eight cats with feline infectious peritonitis and two cats with toxoplasmosis. Abnormalities affecting the CNS were observed in MR images in 10 (71%) cats. Intracranial lesions appeared as slightly hypointense foci in T1-weighted images in two (14%) cats, as hyperintense foci in T2-weighted images in seven (50%) cats and as hyperintense foci after intravenous administration of a gadolinium-based contrast medium in 10 (71%) cats. In six cats with lesions in T1- and/or T2-weighted images, additional lesions were visible in T1-weighted images obtained after gadolinium-based contrast medium administration. In three cats, lesions were visible only after contrast medium administration. In our study, MR imaging (MRI) did not appear to detect all cases of CNS inflammation in the population of cats with inflammatory cerebrospinal fluid (CSF); however, MRI adds information about the sites and morphology of intracranial lesions that should help to distinguish between neoplasia and inflammatory conditions and, possibly, between different inflammatory conditions.
“…17 Detection in the CNS of BDV by immunohistochemistry or of BDV RNA by in situ hybridization, or both, in combination with the clinical and histological findings is considered the most reliable method of confirming BDV meningoencephalomyelitis. 17,21 'Staggering disease' has been reported to affect males more frequently than females, 6,15 while no gender predisposition was observed in the cats included in our study. In a study on 25 cats with 'staggering disease', the mean age at diagnosis was 4.8 years (range 1-12 years) 14 and a recent review article on BDV in Sweden reports an age at diagnosis of 1-4 years in most cats.…”
Section: Discussionmentioning
confidence: 60%
“…5 Other known aetiologies of feline meningoencephalomyelitis are uncommon and include viruses such as feline immunodeficiency virus (FIV), feline leukaemia virus (FeLV), feline parvovirus (FPV), pseudorabies of cats with inflammatory CNS disease other than FIP (35-40%) are found to have histopathological changes consistent with lymphohistiocytic (non-suppurative) meningoencephalomyelitis. 6 This is characterised by perivascular and parenchymal infiltration with lymphocytes, monocytes and plasma cells, usually associated with meningitis and, occasionally, with inflammation of the choroid plexus and the ependyma. 5 Lymphohistiocytic meningoencephalomyelitis is usually suggestive of viral infection; however, the causative agent is often not identified.…”
Twenty-one cats presented with a history of slowly progressive neurological signs characterised by a stiff extended tail, behavioural changes, and spastic and ataxic gait. All cats had outdoor access and lived in the same geographical rural area in north-east Scotland. Histological findings were consistent with lymphohistiocytic meningoencephalomyelitis. Immunohistochemistry ruled out 15 pathogens and showed a significant expression of the interferon-inducible Mx protein, suggesting an as yet unidentified infective or environmental immunogenic trigger as the possible causative agent. The late age at onset (mean 9 years), the very slow progression of clinical signs (mean 11 months) and the peculiar clinical presentation (particularly the posture of the tail) have not been reported previously in cats with lymphohistiocytic meningoencephalomyelitis.
“…The most common cause of meningoencephalitis in cats is feline coronavirus, the etiological agent of feline infectious peritonitis (De Risio et al, 2012). Other known etiologies of feline meningoencephalitis are uncommon and include viruses such as feline immunodeficiency virus (FIV), feline leukemia virus (FeLV), feline parvovirus, pseudorabies virus/ porcine herpesvirus 1, rabies virus, Borna disease virus, West Nile virus, encephalomyocarditis virus, and protozoal, bacterial, rickettsial, fungal and parasitic agents (Gunn Moore, 2005;Schwab et al, 2007). In a large number of feline cases with central nervous disease, histopathological changes consistent with lymphohistiocytic (non-suppurative) meningoencephalitis are found (Schwab et al, 2007).…”
Section: Etiology Of Seizures In Catsmentioning
confidence: 99%
“…Although, lymphohistiocytic meningoencephalitis is usually suggestive of viral infection, the causative agent is often not identified (De Risio et al, 2012). In lymphohistiocytic meningoencephalitis of unknown origin the clinical signs appear at a young age (2 years or less), and the progression is no longer than a couple of weeks (Gunn Moore, 2005;Rand et al, 1994). De Risio (2012) presented different evidence regarding the disease.…”
Epileptic seizures are the most common neurological disorder in the clinical setting. Their etiology is multifactorial and is mainly divided into structural, reactive and idiopathic epilepsy. Structural epilepsy can be caused by vascular events, inflammatory conditions (encephalitis), traumatic injuries, neoplasia, congenital and inherited (degenerative) disorders. Reactive epilepsy is caused by exposure in toxins or metabolic derangements. Although idiopathic epilepsy was thought to be rare in cats, it is now established as a common cause. Epileptic seizures in cats appear with various clinical presentations including generalized, focal with or without secondary generalization epileptic seizures. Diagnostic investigation is crucial in order to establish final diagnosis and to determine the therapeutic plan. Diagnostics include physical and neurological examination with detailed history (drug or toxin exposure), routine hematology (CBC, biochemistry, urinalysis), specific laboratory tests if concurrent or metabolic disease are suspected, advanced diagnostic imaging (CT/MRI) whether intracranial disease is suspected and cerebrospinal fluid (CSF) analysis. Most commonly used antiepileptic drugs (AED) in cats are phenobarbital and levetiracetam. Bromide is contraindicated in cats due to severe respiratory disease caused as an adverse life-threatening reaction. Diazepam is an emergency AED used to eliminate cluster seizures or status epilepticus but it should be avoided as a long-term medication because it has been associated with fatal hepatotoxicity. Gabapentin in another potential antiepileptic drug however its longterm efficacy has to be evaluated. Prognosis depends on the underlying etiology and treatment response. In most cats quality of life is improved and (>50% reduction of epileptic seizures) regardless of etiology. The complete remission of epileptic seizures in cats is rare and most cats should be maintained on anti-epileptic therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.